AMSTERDAM (dpa-AFX) - Royal Philips (PHG) announced it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V. to develop a new handheld blood test to support the care of patients with neuropsychiatric disorders. The blood test will be based on Philips' Minicare I-20 system for immunoassays. Janssen will be responsible for the clinical studies to validate the test, as well as the commercialization of the final product.
The Minicare activities are part of Philips' Handheld Diagnostics business. The business will be expanding its production capacity in light of the new partnership.
Copyright RTT News/dpa-AFX